Simandhar Impex Limited (BSE: 544662) is a very small, recently listed, high‑risk microcap. Based on currently available public data, it looks more like a speculative trading counter than a fundamentally established business.

Below is an objective view.

---

1. Business & background

- Line of business: Wholesale and retail trading of metals, bullion, precious stones and jewellery (gold, silver, platinum, diamonds, silver‑plated articles, etc.). (stockanalysis.com)

- Incorporation: December 2023; registered office in Malad (West), Mumbai. (stockanalysis.com)

- Listing: BSE SME platform, ticker 544662 (Simandhar Impex Ltd). (screener.in)

This is a very young company with almost no operating history as a listed entity.

---

2. Recent change of control & open offer

- On 14 January 2026, Farmico International Pvt. Ltd. signed an SPA to acquire 74.64% of Simandhar Impex at ₹30 per share, total ~₹6.84 crore. (screener.in)

- SEBI Letter of Offer (April 2026) shows an open offer to public shareholders at ₹30 per share for 25.36% of equity (7,75,310 shares), under SEBI SAST. (sebi.gov.in)

- BSE disclosures indicate Farmico completed the 74.64% acquisition on 21 May 2026 and took management control; new directors were appointed on 6 June 2026. (screener.in)

Key implication:

The actual control transaction and open‑offer pricing are at ₹30, while the market price in late June 2026 was around ₹145. (screener.in)

This large gap usually signals speculation/over‑enthusiasm in the trading price versus what the acquirer was willing to pay for control.

---

3. Financials – very small and early‑stage

From the latest available numbers on Screener (FY ending March 2026): (screener.in)

- Scale

- FY26 Sales: ~₹1.54 crore

- FY26 Net profit: ~₹0.01 crore (≈₹1 lakh)

- Equity capital: ~₹3.06 crore (30.57 lakh shares of face value ₹10)

- Profitability

- Operating margin (OPM): ~1.3% in FY26

- Net margin: effectively near 0%

- ROE (last year): ~1%

- ROCE: ~1.15%

- Balance sheet & cash flow

- Market cap (at ~₹145 on 25 June 2026): ~₹44.4 crore

- Total assets: ~₹4.72 crore

- Borrowings: ~₹0.16 crore – almost debt‑free in absolute terms

- Debtor days ~543; working capital days >1,000 (very stretched receivables and working capital).

- Free cash flow is negative; CFO/OP is extremely poor (a sign of weak cash conversion).

In simple terms: tiny revenues, negligible profits, weak cash flows, and very stretched receivables.

---

4. Valuation snapshot (based on historical prices)

At the 25 June 2026 closing price of ₹145 on Screener: (screener.in)

- Market cap: ~₹44.4 crore

- Book value per share: ~₹10.7 → P/B ~13.6x

- EPS (FY26): ~₹0.03 → Screener shows P/E >2,000x due to near‑zero earnings

- 52‑week high/low: ₹181 / ₹21.5

With such low earnings, any P/E is meaningless but clearly extremely high. Price movement has also been very sharp; one independent note pointed to ~380%+ six‑month returns, highlighting strong speculative interest. (kalkine.co.in)

There is also a stark contrast between:

- Open offer/control price: ₹30, and

- Market trading zone in late June: around ₹145, nearly 5x the control price.

For an example of valuation thinking only (not a recommendation):

A microcap with ₹1.54 crore sales and ~₹1 lakh profit, trading at ~₹44 crore market cap and 13‑14x book, while acquirers are buying control at ₹30, would generally be classified as very aggressively valued and speculative on fundamentals.

---

5. Risk factors to be aware of

1. Microcap / SME risk

- Very small equity base and free float; liquidity on SME counters is usually low.

- Entry and exit can be difficult; prices can hit circuits easily and remain there.

2. Business maturity

- Recently incorporated; virtually no long‑term track record of operations, governance, or capital allocation as a listed company.

3. Working‑capital and receivables risk

- Debtor days >500 and >1,000 days working capital indicate cash may be stuck in receivables, raising questions on quality of revenues and counterparties.

4. Cash‑flow quality

- Negative or weak operating cash flows despite “profit” is a red flag in trading‑type businesses.

5. Valuation & price‑discovery risk

- Disconnection between open‑offer/control price (₹30) and market price (trading several times higher) suggests price may be driven by sentiment and low float, not core earnings.

6. Change in promoter / business strategy

- Farmico International now controls the company; actual future business model, scale‑up plans, related‑party dealings and capital‑raising plans will depend entirely on the new management. This is still evolving.

---

6. How to look at it as a retail investor (illustrative only)

Purely as an example framework, an informed investor might:

- Treat Simandhar Impex as a high‑risk, event‑driven microcap, not a steady compounding story at this stage.

- Focus on:

- How business performance changes in FY27–28 under the new promoter (actual growth in sales, margins, and cash flow).

- Whether receivables and working capital ratios normalise.

- Corporate actions, fund‑raising, and any related‑party transactions disclosed in future filings.

- Compare any future market price with:

- Fundamental metrics (sales, EPS, ROE, free cash flow), and

- The ₹30 control/open‑offer benchmark as a reference for how insiders valued the company in 2026.

Until there is a clear track record of consistent profits, clean cash flows, and better working‑capital discipline, this stock, on current data, falls squarely in the speculative, high‑risk bucket from a fundamentals perspective.

All of the above is general analysis and for educational purposes only, not a buy/sell/hold recommendation. For any actual investment decision, you should consider your risk profile, consult a SEBI‑registered advisor, and track the latest BSE disclosures and annual reports.

---

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com